Essais liés4clinical trials
VilleBristollocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT07850063

Ouvrir le site du centre

Essais cliniques associés

4
MoléculeIndication / populationPhaseNCTTitreStatut
Survodutide Maladie rénale chronique Phase 3 NCT06077864 A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT) COMPLETED
Survodutide Maladie coronarienne Phase 3 NCT07850063 ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease NOT_YET_RECRUITING
Dihydroergotamine Migraine Phase 3 NCT04940390 SUMMIT — A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine COMPLETED
Lu AG09222 Migraine Phase 2 NCT06323928 PROCEED — A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments COMPLETED